Do we still need formocresol in pediatric dentistry?

Journal of the Canadian Dental Association

Volumn 71, Issue 10, 2005, Pages 749-751

  Casas, Michael J ^a,b,c   Kenny, David J ^a,b   Judd, Peter L ^b,c   Johnston, Douglas H ^b,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM DERIVATIVE; CALCIUM DERIVATIVE; CARCINOGEN; FERRIC ION; FERRIC SULFATE; FORMALDEHYDE; FORMOCRESOL; MINERAL TRIOXIDE AGGREGATE; MUTAGENIC AGENT; OXIDE; ROOT CANAL FILLING MATERIAL; SILICATE;

ANIMAL; CHEMISTRY; CHILD; DECIDUOUS TOOTH; DENTISTRY; DRUG COMBINATION; ENDODONTICS; HUMAN; METHODOLOGY; SHORT SURVEY;

ALUMINUM COMPOUNDS; ANIMALS; CALCIUM COMPOUNDS; CARCINOGENS; CHILD; DRUG COMBINATIONS; FERRIC COMPOUNDS; FORMALDEHYDE; FORMOCRESOLS; HUMANS; MUTAGENS; OXIDES; PEDIATRIC DENTISTRY; PULPOTOMY; ROOT CANAL FILLING MATERIALS; ROOT CANAL THERAPY; SILICATES; TOOTH, DECIDUOUS;

EID: 29344447040     PISSN: 14882159     EISSN: 14882159     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (27)

1. Hunter ML, Hunter B. Vital pulpotomy in the primary dentition: attitudes and practices of specialists in paediatric dentistry practising in the United Kingdom. Int J Paediatr Dent 2003; 13(4):246-50.
2. Primosch R, Glomb T, Jerrell R. Primary tooth pulp therapy as taught in pediatric dental programs in the United States. Pediatr Dent 1997; 19(2):118-22.
3. Lewis BB, Chestner SB. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. J Am Dent Assoc 1981; 103(3):429-34.
4. Yodaiken RE. The uncertain consequences of formaldehyde toxicity. JAMA 1981; 264(5):1677-8.
5. Perera F, Petito C. Formaldehyde: a question of cancer policy? Science 1982; 216(4552):1285-91.
6. Judd PL, Kenny DJ. Formocresol concerns: a review. J Can Dent Assoc 1987; 53(5):401-4.
7. Lewis BB. Formaldehyde in dentistry: a review for the millennium. J Clin Ped Dent 1998; 22(2):167-77.
8. Ranly DM, Fulton R. Reaction of rat molar pulp tissue to formocresol, formaldehyde and cresol. J Endod 1976; 2(6):176-81.
9. Myers DR, Shoaf HK, Dirksen TR, Pashley DH, Whitford GM, Reynolds KE. Distribution of 14C-formaldehyde after pulpotomy with formocresol. J Am Dent Assoc 1978; 96(5):805-13.
10. King SRA, McWhorter AG, Seale NS. Concentration of formocresol used by pediatric dentists in primary tooth pulpotomy. Pediatr Dent 2002; 24(2):157-9.
11. Pashley EL, Myers DR, Pashley DH, Whitford GM. Systemic distribution of 14C-formaldehyde from formocresol-treated pulpotomy sites. J Dent Res 1980; 59(3):602-7.
12. Ranly DM. Assessment of the systemic distribution and toxicity of formaldehyde following pulpotomy treatment: part one. ASDC J Dent Child 1985; 52(6):431-4.
13. Block RM, Lewis RD, Sheats JB, Burke SG. Antibody formation to dog pulp tissue altered by formocresol within the root canal. Oral Surg Oral Med Oral Pathol 1978; 45(2):282-92.
14. Swenberg JA, Kerns WD, Mitchell RI, Gralla EJ, Pavkov KL. Induction of squamous cell carcinomas of the rat nasal cavity by inhalation exposure to formaldehyde vapor. Cancer Res 1980; 40(9):3398-402.
15. Kerns WD, Pavkov KL, Donofrio DJ, Gralla EJ, Swenberg JA. Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res 1983; 43(9):4382-92.
16. Bolt HM. Experimental toxicology of formaldehyde. J Cancer Res Clin Oncol 1987; 113(4):305-9.
17. Zarzar PA, Rosenblatt A, Takahashi CS, Takeuchi PL, Costa Junior LA. Formocresol mutagenicity following primary tooth pulp therapy: an in vivo study. J Dent 2003; 31(7):479-85.
18. International Agency for Research on Cancer, World Health Organization, Press Release No. 153, June 15, 2004. Available from: URL: http://www.iarc.fr/ ENG/Press_Releases/archives/pr153a.html (accessed October 7, 2005).
19. Nadin G, Goel BR, Yeung CA, Glenny AM. Pulp treatment for extensive decay in primary teeth (Cochrane Review) In: The Cochrane Library. Oxford: Update Software 2003; Issue 1:1-45.
20. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357(9263):1191-4.
21. Ibricevic H, Al-Jame Q. Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow-up study. Eur J Paediatr Dent 2003; 4(1):28-32.
22. Loh A, O'Hoy P, Tran X, Charles R, Hughes A, Kubo K, Messer LB. Evidence-based assessment: evaluation of the formocresol versus ferric sulfate primary molar pulpotomy. Pediatr Dent 2004; 26(5):401-9.
23. Casas MJ, Kenny DJ, Johnston, DH, Judd, PL. Long-term outcomes of primary molar ferric sulfate pulpotomy and root canal therapy. Pediatr Dent 2004; 26(1):44-8.
24. Shaw DH, Krejci RF, Kalkwarf KL, Wentz FM. Gingival response to retraction by ferric sulfate (Astringedent). Oper Dent 1983; 8(4):142-7.
25. Epstein E, Maibach HI. Monsel's solution: history, chemistry and efficacy. Arch Dermatol 1964; 90:226-8.
26. Huang TH, Ding SJ, Hsu TZ, Lee ZD, Kao CT. Root canal sealers induce cytotoxicity and necrosis. J Mater Sci Mater Med 2004; 15(7):767-71.
27. Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate vs. formocresol in pulpotomized primary molars: a preliminary report. Pediatr Dent 2001; 23(1):15-8.